12.10.2017 23:00:00
|
BTB announces its distribution for the month of October 2017
MONTRÉAL, Oct. 12, 2017 /CNW Telbec/ - BTB Real Estate Investment Trust (TSX: BTB.UN) announced today that the monthly cash distribution for the month of October 2017 is $0.035 per unit, representing $0.42 per unit on an annualized basis. The cash distribution will be paid on November 15, 2017 to unitholders of record on October 31, 2017.
About BTB
BTB is a real estate investment trust listed on the Toronto Stock Exchange. BTB is an important owner of properties in eastern Canada. Today, BTB owns 70 retail, office and industrial properties for a total leasable area of 5.1 million square feet. BTB's asset value is approximately $675M. The objectives of BTB are: i) to grow its revenues from its assets to increase distributable income and therefore fund distributions; (ii) to maximize the value of its assets through dynamic management of its properties in order to sustain the long-term value of its units; and (iii) to generate cash distributions that are fiscally beneficial to unitholders.
BTB offers a distribution reinvestment plan to unitholders whereby the participants may elect to have their monthly cash distribution reinvested in additional units of BTB at a price based on the weighted average price for BTB's Units on the Toronto Stock Exchange for the five trading days immediately preceding the distribution date, discounted by 3%.
SOURCE BTB Real Estate Investment Trust
![](https://images.finanzen.at/images/unsortiert/wertpapierdepot-absichern-aktienchart-boerse-750493204-260.jpg)
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Novartis AG (Spons. ADRS)mehr Nachrichten
11.02.25 |
Novartis investiert Milliarden in US-Unternehmen Anthos Therapeutics - Aktie höher (Dow Jones) | |
31.01.25 |
Novartis-Aktie zieht an: Novartis erhöht Dividende nach beeindruckendem Umsatz- und Gewinnplus (finanzen.at) | |
30.01.25 |
Ausblick: Novartis öffnet die Bücher zum abgelaufenen Quartal (finanzen.net) | |
21.01.25 |
Novartis-CEO: Gesundheitspolitik der US-Regierung könnte sich unter Trump verbessern - Novartis-Titel höher (Dow Jones) | |
16.01.25 |
Erste Schätzungen: Novartis legt Zahlen zum jüngsten Quartal vor (finanzen.net) | |
21.11.24 |
Neue Markteinführungen beflügeln: Novartis sieht stärkere Umsatzzuwächse bis 2028 - Novartis-Aktie dennoch tiefer (finanzen.at) | |
29.10.24 |
Novartis nach gutem dritten Quartal zuversichtlicher - Aktie dennoch verlustreich (Dow Jones) | |
28.10.24 |
Ausblick: Novartis stellt Ergebnisse des abgelaufenen Quartals vor (finanzen.net) |
Analysen zu Novartis AG (Spons. ADRS)mehr Analysen
Aktien in diesem Artikel
Novartis AG (Spons. ADRS) | 101,50 | -0,49% |
|